Wells Fargo’s Bio-Path Holdings Inc BPTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-1
Closed -$1 7380
2024
Q4
$1 Buy
+1
New +$1 ﹤0.01% 7042
2024
Q2
Sell
-5
Closed -$20 7747
2024
Q1
$20 Hold
5
﹤0.01% 7125
2023
Q4
$44 Buy
5
+1
+25% +$11 ﹤0.01% 6960
2023
Q3
$31 Buy
4
+1
+33% +$14 ﹤0.01% 7060
2023
Q2
$101 Hold
3
﹤0.01% 6864
2023
Q1
$76 Buy
3
+1
+50% +$36 ﹤0.01% 7000
2022
Q4
$74 Hold
2
﹤0.01% 6880
2022
Q3
$0 Hold
2
﹤0.01% 7643
2022
Q2
$0 Hold
2
﹤0.01% 7755
2022
Q1
$0 Hold
2
﹤0.01% 8088
2021
Q4
$0 Hold
2
﹤0.01% 8031
2021
Q3
$0 Hold
2
﹤0.01% 7707
2021
Q2
$0 Hold
2
﹤0.01% 7645
2021
Q1
$0 Hold
2
﹤0.01% 7565
2020
Q4
$0 Buy
2
+1
+100% +$75 ﹤0.01% 7198
2020
Q3
$0 Hold
1
﹤0.01% 7090
2020
Q2
$0 Sell
1
-2
-67% -$207 ﹤0.01% 6996
2020
Q1
$0 Buy
3
+1
+50% +$119 ﹤0.01% 6993
2019
Q4
$0 Sell
2
-25
-93% -$4.7K ﹤0.01% 6842
2019
Q3
$5K Hold
27
﹤0.01% 6079
2019
Q2
$7K Sell
27
-30
-53% -$9.51K ﹤0.01% 5989
2019
Q1
$23K Buy
57
+54
+1,800% +$9.93K ﹤0.01% 5507
2018
Q4
$0 Hold
3
﹤0.01% 6673
2018
Q3
$1K Hold
3
﹤0.01% 6336
2018
Q2
$2K Hold
3
﹤0.01% 6208
2018
Q1
$3K Hold
3
﹤0.01% 6159
2017
Q4
$3K Hold
3
﹤0.01% 6158
2017
Q3
$5K Hold
3
﹤0.01% 6037
2017
Q2
$5K Sell
3
-17
-85% -$35.6K ﹤0.01% 5935
2017
Q1
$66K Buy
20
+10
+100% +$36.3K ﹤0.01% 5357
2016
Q4
$56K Buy
10
+2
+25% +$9.69K ﹤0.01% 5352
2016
Q3
$46K Hold
8
﹤0.01% 5333
2016
Q2
$66K Buy
8
+7
+700% +$70.9K ﹤0.01% 5071
2016
Q1
$14K Hold
1
﹤0.01% 5601
2015
Q4
$6K Hold
1
﹤0.01% 5857
2015
Q3
$6K Sell
1
-2
-67% -$9.38K ﹤0.01% 5825
2015
Q2
$12K Buy
3
+2
+200% +$10.9K ﹤0.01% 5764
2015
Q1
$7K Hold
1
﹤0.01% 5749
2014
Q4
$9K Hold
1
﹤0.01% 5687
2014
Q3
$7K Hold
1
﹤0.01% 5739
2014
Q2
$16K Buy
+1
New +$11K ﹤0.01% 5474

Other funds holding BPTH

Wells Fargo's BPTH Position: Q1 2025 in Review

Wells Fargo sold out of Bio-Path Holdings Inc (BPTH) in Q1 2025, closing a stake of 1 share — an estimated $1 sold.

Wells Fargo first reported a position in BPTH in Q2 2014 and held it in 41 quarters. The position peaked at $66K in Q1 2017. 2 funds tracked by Wall St. Rank hold BPTH as of Q1 2025.

  • Wells Fargo reported no remaining Bio-Path Holdings Inc position as of Q1 2025 after selling out during the quarter.
  • Wells Fargo sold 1 Bio-Path Holdings Inc share in Q1 2025, an estimated $1.
  • Wells Fargo first reported a position in Bio-Path Holdings Inc in Q2 2014 and held it in 41 quarters.
  • Wells Fargo's Bio-Path Holdings Inc position peaked at $66K in Q1 2017.
  • 2 funds tracked by Wall St. Rank held Bio-Path Holdings Inc as of Q1 2025.

Based on Wells Fargo's 13F filing for Q1 2025, filed 13 May 2025.